Est. 2001·3,000+ placements · six offices · four regions
Flourish — source image

Image via Crunchbase News

Capital Raisingcurated sourcedetected 2026-07-22 · confidence 95%

Last updated

Flourish: Capital Raising

New York-based Flourish raised $500 million Series A from Jeff Bezos, Lux Capital, GV, and Catalio Capital Management. Building neuroscience-inspired Cortex AI architecture with lower power consumption. Less than 1-year-old, valued at $2.5 billion.

Source: Crunchbase News

The leadership read

Flourish's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Americas.

Market context: The wider read — a Talent Market Index of 104.6 (Hot), down 1.9 month-on-month — shows Americas signal flow rising (+2.1pts).

Flourish: 2 signals in the last 90 days; 0.1% of MitchelLake's Americas signal flow; 2 tracked across 47 days.

MitchelLake in this thematic

Also at Flourish

More signals across Americas

Capital Raising · Americas

Maximum

Maximum, an AI-focused core banking software provider founded by fintech entrepreneur Randy Fernando, closed a $30 million seed funding round. The company is positioning itself as a challenger to incumbent core banking platforms.

Capital Raising · Americas

TENEX.AI

TENEX.AI raised $250 million in funding and achieved unicorn status (valuation >$1 billion). The company develops AI-native security operations centers that classify all alerts and investigate threats within SLA windows while maintaining human oversight for critical decisions.

Capital Raising · Americas

KKR

KKR and Canada Pension Plan co-invested US$10 billion in Sempra Infrastructure Partners, marking large-scale infrastructure financing into hard assets.

Capital Raising · Americas

Optiml

Optiml, a developer of software to support real estate decarbonization, closed a seed round in the $5M-$10M range as part of proptech investment activity.

Capital Raising · Americas

Ratio Therapeutics

Ratio Therapeutics closed a Series C funding round of $70M for radiopharmaceutical trials, led by existing investors Duquesne Family Office and Bristol Myers Squibb, with new investor participation.

Capital Raising · Americas

BoxGroup

BoxGroup demonstrated 9 active investments across NYC startups in Q2 2026, including participation in mega-rounds like Ramp's $750M Series F and early-stage deals like Ornn AI's $33M seed, signaling sustained fundraising capacity and deployment velocity across growth stages.

Weekly briefing

Track companies like Flourish — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Nearby in the record